Bridgeway Capital Management’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bridgeway Capital Management’s Portfolio LHDX Stock Details LHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-110,500	Closed	-$12.3K	–	1458
2022 Q4	$12.3K	Sell	110,500 -14,200	-11%	-$9.06K	﹤0.01%	1356
2022 Q3	$132K	Buy	124,700 +37,000	+42%	+$84.3K	﹤0.01%	1222
2022 Q2	$163K	Buy	+87,700	New	+$213K	﹤0.01%	1134

Other funds holding LHDX

Eclipse Ventures Palo Alto, California $2.57B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Resolute Advisors San Francisco, California $417M AUM 60.99% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Bridgeway Capital Management's LHDX Position: Q1 2023 in Review

Bridgeway Capital Management sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 110,500 shares — an estimated $12.3K sold.

Bridgeway Capital Management first reported a position in LHDX in Q2 2022 and held it in 3 quarters. The position peaked at $163K in Q2 2022. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

Bridgeway Capital Management reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Bridgeway Capital Management sold 110,500 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $12.3K.
Bridgeway Capital Management first reported a position in Lucira Health, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
Bridgeway Capital Management's Lucira Health, Inc. Common Stock position peaked at $163K in Q2 2022.
6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on Bridgeway Capital Management's 13F filing for Q1 2023, filed 15 May 2023.